Skip to content
You can now search across every topic, entity and event.What's new
UK Startups and Innovation
21SEP

UK Horizon Europe share rebounds to 9.3%

3 min read
16:52UTC

DSIT data published on 5 June show the UK's Horizon Europe funding share rose to 9.3% in 2024 from 5.8% a year earlier, with the applied-research strand up 68%, a genuine recovery that still sits below the pre-Brexit peak.

TechnologyDeveloping
Key takeaway

UK Horizon Europe recovery is real and feeds the spinout pipeline, but sits below the 2018/19 peak.

DSIT published UK participation figures for the EU's Horizon Europe research programme on Friday 5 June. The UK's share of funding won rose to 9.3% in 2024, from 5.8% in 2023, worth €994m, with its share of proposals climbing from 18.9% to 24.1%. The department described the result as a partial recovery toward late Horizon 2020 levels, still below the 2018/19 peak. 1

Horizon Europe is the EU's flagship research programme; the UK re-associated in 2024 after Brexit exclusion. The sharpest move sits in Pillar 2, the strand funding industrial and applied collaborative research that feeds university tech-transfer offices and spinouts. The UK's Pillar 2 share rose 68% year on year, from 3.7% to 6.2%. The part of the recovery most likely to surface later as commercial IP is also the part growing fastest.

DSIT's own framing keeps the ceiling in view. Re-association has reopened the collaborative-funding pipe, but it is not yet running at pre-Brexit volume. The France science alliance signed in May is the bilateral hedge that runs alongside the multilateral programme, a second channel for the same collaborative research while Horizon participation climbs back toward where it was.

Deep Analysis

In plain English

Horizon Europe is the European Union's main research funding programme, with a total budget of roughly €95bn for 2021-2027. The UK was excluded from it after Brexit until re-association in early 2024. In 2023, the UK's share of Horizon funding was 5.8%. In 2024, it recovered to 9.3%, meaning UK researchers won €994m of grants. The applied-research strand (Pillar 2) recovered fastest, growing 68% year-on-year. However, DSIT itself describes this as a partial recovery: before Brexit, the UK had a larger share. Getting back to pre-Brexit levels requires winning a higher proportion of the proposals that UK researchers are submitting, which depends partly on Brussels relationships that were disrupted during three years of exclusion.

Deep Analysis
Root Causes

Pillar 2 (industrial research consortia) recovered faster than Pillar 1 (curiosity-driven ERC) for structural reasons. Pillar 2 projects involve industrial consortia where UK companies remain commercially attractive partners regardless of political status. A German automotive manufacturer running a battery electrolyte consortium has direct commercial reasons to include a UK material-science team even under associate rules.

ERC individual grants differ: UK researchers compete head-to-head against EU nationals in peer-review panels where the 2021-2023 exclusion period broke the informal network ties that referees use to assess applicants. Rebuilding those networks takes the length of a grant cycle, roughly 5-7 years, which is why the Pillar 1 recovery lags.

What could happen next?
  • Consequence

    Pillar 2 grants awarded in 2024 will produce commercial IP and spinout companies in 2029-2032. The 68% year-on-year growth means the UK spinout pipeline from Horizon is growing again after a four-year gap.

  • Risk

    The UK's 24.1% proposal share suggests strong research intent but a still-recovering award conversion rate. If consortium-formation biases persist, the actual funding return may plateau before recovering to pre-Brexit levels.

First Reported In

Update #7 · OQC's £260m sets European quantum record

UK Tech News· 7 Jun 2026
Read original
Causes and effects
This Event
UK Horizon Europe share rebounds to 9.3%
The 68% jump in Pillar 2 is a leading indicator for future UK tech transfer and spinout volume, rather than a diplomatic recovery metric.
Different Perspectives
Nscale and Open Cosmos
Nscale and Open Cosmos
Nscale chose the New York Stock Exchange for its listing on 18 September, putting Britain's largest AI infrastructure bet to American public investors rather than British ones. Open Cosmos took the opposite route four days earlier, raising nine figures from an all-domestic syndicate on five years of profit, evidence that staying is possible when the balance sheet allows it.
Dame Chi Onwurah and the Science, Innovation and Technology Committee
Dame Chi Onwurah and the Science, Innovation and Technology Committee
Committee chair Dame Chi Onwurah wrote to government on 7 September asking how Matt Clifford's conflict at ARIA arose and what safeguards protect its governance, and expects a detailed response. Her question has not yet been put to the Sovereign AI Unit, whose own chair sits at a venture capital firm while overseeing state AI equity.
The Entrepreneurs Network
The Entrepreneurs Network
The Entrepreneurs Network's founder survey found 65% say Britain is easy to start a business in but only 14% say it is easy to scale one, with 82% negative on tax and 74% finding investment hard to access. On this reading the constraint is regulation and tax, not the capital-vehicle design the state keeps adjusting.
New Economics Foundation
New Economics Foundation
The New Economics Foundation argues fiscal accounting rules, not political will, cap what Britain's state capital vehicles can do. Matching the KfW and Bpifrance benchmark of 1% of GDP would need the National Wealth Fund to deploy roughly GBP21bn a year by 2028-29, about four times its current capacity.
Competition and Markets Authority
Competition and Markets Authority
The CMA's 8 September report on public procurement asked whether Britain's roughly GBP400bn state-spending system is built to grow high-potential firms rather than simply widen SME participation. Its Recommendation 5 calls for a dedicated frontier-technology procurement framework, an official acknowledgement that today's design may serve the wrong target.
Highland Europe
Highland Europe
Highland Europe, the growth-equity firm behind a €1bn-plus fund, took €65m from the British Business Bank into its Technology Growth Fund VI on 30 July via British Patient Capital. For a Geneva-based growth investor, the Bank's cheque is routine cornerstone capital, unrelated to which Whitehall department currently claims to sponsor UKRI.